Internal Medicine Doctors in Merrillville, IN Accepting Medicare

68 Internal Medicine doctors found. Showing 61 - 68

Hakam H Safadi, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8909 Broadway, Merrillville, IN 46410 Phone: 219-769-0054    Fax: 219-769-1793

Dr. Kmlst Moorthi, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 90 W 86th Ave, Nephrology Associates Of Northern Indiana, Merrillville, IN 46410 Phone: 219-791-1555    Fax: 219-791-0679

Ahmad F Zegar, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 8701 Broadway, Merrillville, IN 46410 Phone: 219-738-5510    Fax: 219-738-6714

Vallee M. Adams-miller, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 8777 Broadway, Merrillville, IN 46410 Phone: 219-736-5151    Fax: 219-736-1506

Rupesh J. Shah, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 E 86th Pl, Merrillville, IN 46410 Phone: 219-756-7910    Fax: 219-756-7810

Rafael Fletes, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 90 W 86th Ave, Merrillville, IN 46410 Phone: 219-791-1555    Fax: 197-911-5602

Dr. Preeti K Gurnani, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9229 Taft St, Merrillville, IN 46410 Phone: 219-769-5227    Fax: 219-932-8455

Mark Fesenmyer, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8895 Broadway, Merrillville, IN 46410 Phone: 219-738-2081    Fax: 219-736-4658

News Archive

Update on Nymox Pharmaceutical's Phase 3 program for NX-1207

Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia. The most recent Safety Monitoring Committee meeting of April 30, 2010 for the Phase 3 U.S. pivotal trials of NX-1207 indicated no significant safety concerns for the trials to date.

Research findings help explain diverse genetic susceptibility for alcohol use disorders

A genetic variant of a receptor in the brain's reward circuitry plays an important role in determining whether the neurotransmitter dopamine is released in the brain following alcohol intake, according to a study led by researchers at the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health. Dopamine is involved in transmitting the euphoria and other positive subjective effects produced by alcohol.

Study questions benefits of breast cancer screenings as practiced in the real world

A new study calls into question the actual benefits of breast cancer screenings as practiced in the real world, as opposed to the well-controlled situations of previous screening trials. The study appears in the July 20 issue of the Journal of the National Cancer Institute.

Leica introduces new DMi8 S solution for fast, versatile microscopic imaging of living cells

Leica introduces the DMi8 S, a new complete solution designed to give researchers the ultimate tool for fast, versatile microscopic imaging of living cells allowing scientists to find, observe and interact with living cells like never before.

New sweetener from tequila plant may aid diabetes, weight loss

A sweetener created from the plant used to make tequila could lower blood glucose levels for the 26 million Americans and others worldwide who have type 2 diabetes and help them and the obese lose weight, researchers said here today.

Read more Medical News

› Verified 6 days ago

• 1
• 2
• 3
• 4(current)